Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Cell count ratios appear to predict thromboembolism in lymphoma

Key clinical point: In patients with lymphoma undergoing chemotherapy, high neutrophil to lymphocyte (NLR) and platelet to lymphocyte (PLR) ratios appear to predict risk of thromboembolism.

Major finding: A neutrophil to lymphocyte ratio of 3.1 or more was associated with a relative risk of thromboembolism of 4.1 (P less than .001).

Study details: A retrospective study involving 484 patients with lymphoma who had undergone at least one cycle of chemotherapy.

Disclosures: The investigators reported no financial disclosures.

Citation:

Otasevic V et al. EHA Congress, Abstract S1645.